Cargando…
Effect of bortezomib on the treatment of multiple myeloma: a systematic review protocol
INTRODUCTION: Multiple myeloma (MM) is an incurable malignant neoplasm that accounts for approximately 1% of all cancers and 10% of haematological malignancies. Bortezomib is one of the most commonly used medications in first-line treatment and subsequent relapses, either as a single agent or in com...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240935/ https://www.ncbi.nlm.nih.gov/pubmed/35768117 http://dx.doi.org/10.1136/bmjopen-2022-061808 |